But in the wake of the Covid-19 pandemic, the buzz is building to a roar, with international campaigns for change gaining political, corporate and public support. While Four Day Week Ireland is advocating for a transition to a shorter working week for all workers, Microsoft Japan has reported a 39 per cent increase in productivity from a four-day week trial. Spanish left-wing political party Mas Pais is in talks with central government to finalise details of a pilot programme giving workers an extra day off, and the Indian Government is considering policy changes to allow more flexibility for companies looking to implement a four-day week.
Share this article
Share this article
Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal
Novel therapy developed by Australian biotech company, Ena Respiratory, shown in animal study to reduce COVID-19 virus levels in the nose and throat by up to 96%; also found to be effective against rhinovirus (common cold), the
predominant cause of the common cold and exacerbations of chronic respiratory diseases including asthma and COPD
Mode of action complementary to COVID-19 vaccines, once weekly nasal spray to play significant role in reducing COVID-19 community transmission and disease progression in at risk populations